Literature DB >> 28427753

Prognostic markers in oropharyngeal squamous cell carcinoma: focus on CD70 and tumour infiltrating lymphocytes.

Astrid De Meulenaere1, Tijl Vermassen2, Sandrine Aspeslagh3, Karen Zwaenepoel4, Philippe Deron5, Fréderic Duprez6, Sylvie Rottey2, Liesbeth Ferdinande7.   

Abstract

We evaluated the expression of CD70 as biomarker for prognosis in patients with oropharyngeal squamous cell carcinoma (OSCC). We also examined the prognostic value of tumour infiltrating lymphocytes (TILs) in our study cohort. Formalin fixed, paraffin embedded tissue originating from the oropharynx of 78 patients was immunohistochemically stained for CD70, CD3, CD8 and FoxP3. Expression of CD70, CD3, CD8, FoxP3 and HPV status was correlated with clinicopathological characteristics. Overall survival (OS) was determined by a log-rank (Mantel-Cox) test whereas the Cox proportional hazard model was used for multivariate analysis. CD70 expression demonstrated no influence on OS. Tumours heavily infiltrated by TILs were linked with better outcome, for the total number of TILs as well as for the CD3+ and CD8+ T cell count. A Cox proportional hazard model proved that solely CD8+ infiltrating T cells exhibit a positive effect on OS (HR=0.30, 95% confidence interval 0.13-0.72). Our results demonstrate that CD8+ TILs constitute an independent prognosticator in patients diagnosed with OSCC. Further validation of the prognostic value of CD8+ TILs in OSCC is warranted and could provide us with a better insight into the immunological status of these malignancies.
Copyright © 2017 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CD70; Squamous cell carcinoma of the head and neck; biomarker; oropharynx; tumour infiltrating lymphocytes

Mesh:

Substances:

Year:  2017        PMID: 28427753     DOI: 10.1016/j.pathol.2017.02.002

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  10 in total

1.  Utility of CD8 score by automated quantitative image analysis in head and neck squamous cell carcinoma.

Authors:  Douglas J Hartman; Fahad Ahmad; Robert L Ferris; David L Rimm; Liron Pantanowitz
Journal:  Oral Oncol       Date:  2018-10-11       Impact factor: 5.337

2.  A defect in KCa3.1 channel activity limits the ability of CD8+ T cells from cancer patients to infiltrate an adenosine-rich microenvironment.

Authors:  Ameet A Chimote; Andras Balajthy; Michael J Arnold; Hannah S Newton; Peter Hajdu; Julianne Qualtieri; Trisha Wise-Draper; Laura Conforti
Journal:  Sci Signal       Date:  2018-04-24       Impact factor: 8.192

3.  Prognostic impact of leukocyte counts before and during radiotherapy for oropharyngeal cancer.

Authors:  Garrett L Jensen; Pierre Blanchard; G Brandon Gunn; Adam S Garden; C David Fuller; Erich M Sturgis; Maura L Gillison; Jack Phan; William H Morrison; David I Rosenthal; Steven J Frank
Journal:  Clin Transl Radiat Oncol       Date:  2017-11-06

4.  Impact of HPV Infection on the Immune System in Oropharyngeal and Non-Oropharyngeal Squamous Cell Carcinoma: A Systematic Review.

Authors:  Jerome R Lechien; Imelda Seminerio; Géraldine Descamps; Quentin Mat; Francois Mouawad; Stéphane Hans; Morbize Julieron; Didier Dequanter; Thibault Vanderhaegen; Fabrice Journe; Sven Saussez
Journal:  Cells       Date:  2019-09-10       Impact factor: 6.600

Review 5.  HPV Involvement in the Tumor Microenvironment and Immune Treatment in Head and Neck Squamous Cell Carcinomas.

Authors:  Jérôme R Lechien; Géraldine Descamps; Imelda Seminerio; Sonia Furgiuele; Didier Dequanter; Francois Mouawad; Cécile Badoual; Fabrice Journe; Sven Saussez
Journal:  Cancers (Basel)       Date:  2020-04-25       Impact factor: 6.639

Review 6.  Enhanced Radiation Sensitivity of Human Papillomavirus-Driven Head and Neck Cancer: Focus on Immunological Aspects.

Authors:  Mine Özcan-Wahlbrink; Christoph Schifflers; Angelika B Riemer
Journal:  Front Immunol       Date:  2019-12-03       Impact factor: 7.561

7.  Editorial: Advances in the Involvement of Human Papilloma Virus in Head and Neck Squamous Cell Carcinoma.

Authors:  Jerome R Lechien; Francois Mouawad; Stéphane Hans; Sven Saussez
Journal:  Front Oncol       Date:  2022-03-03       Impact factor: 6.244

8.  Development of Exhaustion and Acquisition of Regulatory Function by Infiltrating CD8+CD28- T Lymphocytes Dictate Clinical Outcome in Head and Neck Cancer.

Authors:  Daniela Fenoglio; Liliana Belgioia; Alessia Parodi; Francesco Missale; Almalina Bacigalupo; Alison Tarke; Fabiola Incandela; Simone Negrini; Stefania Vecchio; Tiziana Altosole; Sara Vlah; Giuseppina Astone; Francesca Costabile; Alessandro Ascoli; Francesca Ferrera; Guido Schenone; Raffaele De Palma; Alessio Signori; Giorgio Peretti; Renzo Corvò; Gilberto Filaci
Journal:  Cancers (Basel)       Date:  2021-05-06       Impact factor: 6.639

9.  Tumor PD-L1 status and CD8+ tumor-infiltrating T cells: markers of improved prognosis in oropharyngeal cancer.

Authors:  Astrid De Meulenaere; Tijl Vermassen; Sandrine Aspeslagh; Philippe Deron; Fréderic Duprez; Debby Laukens; Jo Van Dorpe; Liesbeth Ferdinande; Sylvie Rottey
Journal:  Oncotarget       Date:  2017-07-06

Review 10.  Tumor-Infiltrating Lymphocytes in Head and Neck Cancer: Ready for Prime Time?

Authors:  Alhadi Almangush; Stijn De Keukeleire; Sylvie Rottey; Liesbeth Ferdinande; Tijl Vermassen; Ilmo Leivo; Antti A Mäkitie
Journal:  Cancers (Basel)       Date:  2022-03-18       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.